by adminTorusBrand | Feb 8, 2017 | Company News, HempMeds Brasil, Scientific Research
The Brazilian health authority has approved the importation of HempMeds® CBD hemp oil product RSHO™ for patient diagnosed with Alzheimer’s disease. HempMeds® Brasil, a Medical Marijuana, Inc. portfolio company and the local distribution branch for Medical Marijuana,...
by adminTorusBrand | Feb 7, 2017 | HempMeds Brasil, Press Releases
National Health Surveillance Agency ANVISA Authorizes Doctor’s Prescription for RSHO™ to Treat Patient Suffering from Effects of Alzheimer’s Disease SAN DIEGO, Feb. 7, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly...
by adminTorusBrand | Feb 2, 2017 | HempMeds Brasil, Press Releases
SAN DIEGO, Feb. 2, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds Brasil™ has launched a new website featuring brand information, a navigable web...
by adminTorusBrand | Feb 1, 2017 | HempMeds Brasil, Press Releases
AN DIEGO, Feb. 1, 2017 — Medical Marijuana, Inc. (otc pink:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Brasil has begun the process of importing its Real Scientific Hemp Oil™ (RSHO) Green...
by adminTorusBrand | Jan 12, 2017 | HempMeds Brasil, Media Coverage, Press Releases
Medical Marijuana, Inc. subsidiary’s success in Latin America highlighted on syndicated Lars Larson Northwest Podcast. Earlier this week, the medical uses of cannabis were featured on the popular Lars Larson Northwest Podcast as Blake Schroeder, VP of Operations for...
